98%
921
2 minutes
20
Dementia specialists-neurologists, geriatricians, and geriatric psychiatrists-serve a critical clinical function in diagnosing early-stage Alzheimer's disease and determining eligibility for treatment with disease-modifying therapies. However, the availability of dementia specialists is limited and varies across the United States. Using data from the Area Health Resources Files, we found that the median density of dementia specialists across hospital referral regions in United States is 28.8 per 100 000 population aged 65 years and older (interquartile range 19.3-43.6). We derived thresholds of 33-45 dementia specialists per 100 000 population aged 65 years and older as the provider density necessary to care for older adults with mild cognitive impairment and dementia. Based on these thresholds, we estimated that 34%-59% of the population aged 65 years and older resided in areas with potential dementia specialist shortfalls. The extent of potential shortfalls varied by state and rurality. A better understanding of potential gaps in the availability of dementia specialists will inform policies and practices to ensure access to services for people with cognitive impairment and dementia.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11288326 | PMC |
http://dx.doi.org/10.1093/haschl/qxae088 | DOI Listing |
J Am Geriatr Soc
September 2025
Department of Family Medicine, Faculty of Medicine, McGill University, Montreal, Canada.
Background: Ensuring equitable healthcare services for persons with dementia is of utmost importance. Recent evidence points to sex-based differences in healthcare use in this population. However, available evidence is based on data from limited geographic regions and predates the COVID-19 pandemic, which is said to have further magnified disparities.
View Article and Find Full Text PDFPalliat Support Care
September 2025
School of Medicine, The University of Sydney, Camperdown, NSW, Australia.
Objectives: This study explored Australian palliative care clinicians' perspectives on the legalization of voluntary assisted dying (VAD), aiming to identify variables associated with clinicians' views and understand challenges of its implementation.
Methods: An online survey exploring support for legalization of VAD was sent to palliative care clinicians in Queensland and New South Wales and followed up with semi-structured interviews. Support was categorized as positive, uncertain, or negative.
Rural Remote Health
August 2025
Department of Clinical Research and Quality Management, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
Introduction: Deterioration of chronic conditions and serious acute illnesses are major factors preventing older individuals from remaining within their local communities, which may be significant burdens for islanders. The specific reasons and risk factors associated with non-returned off-island referrals remain insufficiently investigated. This study aims to describe cases of non-return after off-island referrals and to examine the relationship between polypharmacy and non-returned off-island referral among older residents regularly attending remote island clinics.
View Article and Find Full Text PDFHealth Serv Res
August 2025
Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Objective: To evaluate the effects of physician and advanced practitioner specialization in skilled nursing facility (SNF)-based practice (SNFists) on the outcomes of patients with Alzheimer's disease and related dementias (ADRD) admitted to SNF for post-acute care.
Study Setting And Design: Taking advantage of the natural experiment provided by the growth of SNFists, we conducted a within-SNF difference-in-differences analysis with cross-temporal matching. Our primary outcome was functional improvement at SNF discharge, measured using a validated activities of daily living (ADL) score.
J Prev Alzheimers Dis
August 2025
Division of Geriatrics, Department of Medicine, Queen Mary Hospital, Hong Kong.
Early diagnosis of mild cognitive impairment (MCI) and Alzheimer's disease (AD) with mild dementia is becoming increasingly important to enable patients to receive appropriate treatment with available amyloid-targeting therapies. Reviews of AD prevalence and diagnostic and treatment patterns typically focus on global or western populations, but the situation in Asia, Australasia, and Pacific Nations (AAPN) countries is less clear. We performed a narrative review of literature for AD in several AAPN countries, focusing on patients with MCI or mild dementia who may benefit from early treatment.
View Article and Find Full Text PDF